On the Rise: ENHERTU’s Journey Through Cancer Therapeutics
The deruxtecan component exhibits remarkable cytotoxic efficacy combined with superior tumor penetration characteristics, ensuring optimal therapeutic outcomes while minimizing systemic adverse effects
